Stay updated on Relamorelin in Diabetic Gastroparesis Clinical Trial
Sign up to get notified when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.

Latest updates to the Relamorelin in Diabetic Gastroparesis Clinical Trial page
- Check7 days agoChange DetectedThe webpage has undergone significant content removal, particularly regarding the details of a clinical study on relamorelin for diabetic gastroparesis, including the study's purpose, inclusion and exclusion criteria, and the study director's name. The version number has also been updated from v2.14.4 to v2.15.0.SummaryDifference23%
- Check14 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check72 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
- Check80 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Relamorelin in Diabetic Gastroparesis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.